Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a transesophageal echocardiographic study in 500 patients with cerebral ischemia

J Am Soc Echocardiogr. 2005 Dec;18(12):1366-72. doi: 10.1016/j.echo.2005.05.006.

Abstract

Background: Hemostasis in the left atrial (LA) appendage (LAA) is an important cause in the formation of thrombi. Determination of the LAA flow velocity (LAAV) could be a quantitative parameter for estimating thromboembolic risk. The objective of this study was to: (1) determine the relationship between LAAV and qualitative parameters with elevated thromboembolic risk (thrombus/spontaneous echocontrast [SEC]); and (2) define factors that influence LAAV.

Methods: In all, 500 patients with stroke were examined consecutively by transesophageal echocardiography. In addition to measurement of the LAAV, the atrial appendage was examined for the presence of thrombi or SEC.

Results: LAAV differed significantly among patients with sinus rhythm (71 +/- 16 cm/s), paroxysmal atrial fibrillation (AF) and in sinus rhythm during transesophageal echocardiography (46 +/- 13 cm/s), paroxysmal AF and AF during transesophageal echocardiography (32 +/- 12 cm/s), and chronic AF (27 +/- 9 cm/s, P < .001). Independent of the rhythm, the risk of thrombus/SEC increased significantly at an LAAV less than 55 cm/s. At an LAAV 55 cm/s or more there is only a minimal risk of thrombus/SEC (negative predictive value 100% and 99%, respectively). Multivariate analysis showed that LAAV is the strongest predictor for the occurrence of thrombus/SEC (P < .0001). Further multivariate analysis showed that left ventricular ejection fraction, LA size, (paroxysmal) AF, age, and sex are independent parameters influencing LAAV.

Conclusion: Independent of the basic rhythm, there is a close relationship between LAAV and qualitative parameters of elevated thromboembolic risk. LAAV could, therefore, be a quantitative surrogate parameter for risk stratification. It is influenced by both cardiac and extracardiac factors.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Atrial Appendage / diagnostic imaging*
  • Blood Flow Velocity
  • Brain Ischemia / diagnostic imaging*
  • Brain Ischemia / epidemiology
  • Comorbidity
  • Echocardiography / methods*
  • Echocardiography / statistics & numerical data
  • Echocardiography, Transesophageal / methods*
  • Echocardiography, Transesophageal / statistics & numerical data
  • Female
  • Germany / epidemiology
  • Heart Diseases / diagnostic imaging*
  • Heart Diseases / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Risk Assessment / methods
  • Risk Factors
  • Thrombosis / diagnostic imaging*
  • Thrombosis / epidemiology